Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8710226 Process for the preparation of morphinane analogues

Patent 8710226 was granted and assigned to Sun Pharmaceutical on April, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12018304 Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
0
Edits on 3 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11859225 Methods of producing epimerases and benzylisoquinoline alkaloids
0
Edits on 2 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 2 Dec, 2023
Edits made to:
Article (+115 characters)
Article

Patent abstract

The present invention relates to an improved process for preparing morphinane analogues of formula 1

Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08710226 Process for the preparation of morphinane analogues US Patent 8710226 Process for the preparation of morphinane analogues

Infobox
Patent Number
0871022600
Patent Number
871022600
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0871022600
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Sun Pharmaceutical
Sun Pharmaceutical
0
Current Assignee
Sun Pharmaceutical
Sun Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
087102260
Date of Patent
April 29, 2014
0
Patent Application Number
140138730
Date Filed
August 29, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087102260
Patent Primary Examiner
‌
Charanjit Aulakh
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Sun Pharmaceutical
Sun Pharmaceutical
0
Current Assignee
Sun Pharmaceutical
Sun Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
087102260
Date of Patent
April 29, 2014
0
Patent Application Number
140138730
Date Filed
August 29, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087102260
Patent Primary Examiner
‌
Charanjit Aulakh
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08710226
Edits on 23 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 23 Dec, 2021
Edits made to:
Infobox (+9 properties)
‌

 US Patent 08710226 Process for the preparation of morphinane analogues

Infobox
Is a
Patent
Patent
Patent applicant
Sun Pharmaceutical
Sun Pharmaceutical
Current assignee
Sun Pharmaceutical
Sun Pharmaceutical
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08710226
Date of patent
April 29, 2014
Patent application number
14013873
Date Filed
August 29, 2013
Patent primary examiner
‌
Charanjit Aulakh

Find more entities like US Patent 8710226 Process for the preparation of morphinane analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.